• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).

作者信息

Arlen Philip M, Pazdur Mary, Skarupa Lisa, Rauckhorst Myrna, Gulley James L

机构信息

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892-1750, USA.

出版信息

Clin Breast Cancer. 2006 Jun;7(2):176-9. doi: 10.3816/CBC.2006.n.032.

DOI:10.3816/CBC.2006.n.032
PMID:16800982
Abstract
摘要

相似文献

1
A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).一项关于多西他赛单独使用或与PANVAC-V（痘苗病毒）和PANVAC-F（鸡痘病毒）联合用于转移性乳腺癌患者的随机II期研究（NCI 05-C-0229）。
Clin Breast Cancer. 2006 Jun;7(2):176-9. doi: 10.3816/CBC.2006.n.032.
2
Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer.多西他赛单药治疗转移性乳腺癌的I-II期研究。
Semin Oncol. 1999 Jun;26(3 Suppl 8):21-6.
3
Review of docetaxel/doxorubicin combination in metastatic breast cancer.多西他赛/阿霉素联合治疗转移性乳腺癌的综述。
Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):31-3.
4
Phase III randomized trials of docetaxel in patients with metastatic breast cancer.多西他赛用于转移性乳腺癌患者的III期随机试验。
Semin Oncol. 1999 Jun;26(3 Suppl 8):33-8.
5
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.多西他赛单药或联合治疗性癌症疫苗（PANVAC）治疗转移性乳腺癌患者：一项随机临床试验。
JAMA Oncol. 2015 Nov;1(8):1087-95. doi: 10.1001/jamaoncol.2015.2736.
6
Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.多西他赛/长春瑞滨联合用于转移性乳腺癌和非小细胞肺癌。
Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):46-9.
7
Docetaxel in combination chemotherapy for metastatic breast cancer.多西他赛用于转移性乳腺癌的联合化疗。
Semin Oncol. 1997 Aug;24(4 Suppl 13):S13-19-S13-26.
8
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.多西他赛与卡培他滨每周给药方案用于转移性乳腺癌患者的II期研究。
Clin Breast Cancer. 2006 Jun;7(2):141-5. doi: 10.3816/CBC.2006.n.023.
9
Single-agent docetaxel (Taxotere) in randomized phase III trials.单药多西他赛（泰索帝）用于随机III期试验。
Semin Oncol. 1999 Jun;26(3 Suppl 9):1-6.
10
A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer.多西他赛单药治疗转移性乳腺癌的疗效与安全性综述。
Semin Oncol. 1999 Feb;26(1 Suppl 3):5-9.

引用本文的文献

1
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies.肿瘤相关抗原的翻译后修饰作为新型免疫肿瘤治疗的平台
Cancers (Basel). 2022 Dec 26;15(1):138. doi: 10.3390/cancers15010138.
2
SIV-Specific Antibodies are Elicited by a Recombinant Fowlpox Virus Co-expressing SIV Gag and envT.共表达SIV Gag和envT的重组鸡痘病毒可诱导产生SIV特异性抗体。
Indian J Microbiol. 2018 Sep;58(3):345-352. doi: 10.1007/s12088-018-0728-y. Epub 2018 Apr 27.
3
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
溶瘤病毒——天然及基因工程癌症免疫疗法
Front Oncol. 2017 Sep 11;7:202. doi: 10.3389/fonc.2017.00202. eCollection 2017.
4
Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.通过靶向树突状细胞的慢病毒载体递送的乳腺癌疫苗可诱导有效的抗肿瘤免疫反应，并保护小鼠免受乳腺肿瘤生长的影响。
Vaccine. 2017 Oct 13;35(43):5842-5849. doi: 10.1016/j.vaccine.2017.09.017. Epub 2017 Sep 12.
5
Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.治疗前外周免疫评分及疫苗治疗反应分析
Cancer Immunol Res. 2016 Sep 2;4(9):755-65. doi: 10.1158/2326-6066.CIR-16-0037. Epub 2016 Aug 2.
6
Tecemotide: an antigen-specific cancer immunotherapy.替西莫肽：一种抗原特异性癌症免疫疗法。
Hum Vaccin Immunother. 2014;10(11):3383-93. doi: 10.4161/hv.29836.
7
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.靶向小分子抑制剂（卡博替尼）与癌症疫苗联合使用时，对免疫介导的肿瘤细胞杀伤和免疫肿瘤微环境允许性的双重作用。
J Transl Med. 2014 Nov 13;12:294. doi: 10.1186/s12967-014-0294-y.
8
Proposed mechanisms of action for prostate cancer vaccines.前列腺癌疫苗的作用机制。
Nat Rev Urol. 2013 Mar;10(3):149-60. doi: 10.1038/nrurol.2013.8. Epub 2013 Feb 12.
9
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.联合治疗的转折点：癌症疫苗与放疗、化疗或靶向小分子抑制剂联合治疗。
Semin Oncol. 2012 Jun;39(3):323-39. doi: 10.1053/j.seminoncol.2012.02.006.
10
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.MUC1-C 癌蛋白作为乳腺癌的治疗靶点：信号通路的激活与治疗方法。
Oncogene. 2013 Feb 28;32(9):1073-81. doi: 10.1038/onc.2012.158. Epub 2012 May 14.